共 50 条
- [1] Use of national guidelines for the introduction of Drotrecogin alfa (activated) [J]. Critical Care, 8 (Suppl 1):
- [4] Strategies to optimize drotrecogin alfa (activated) use: Guidelines and therapeutic controversies [J]. PHARMACOTHERAPY, 2002, 22 (12): : 223S - 235S
- [5] Multicentre audit of the use of drotrecogin alfa (activated) in UK critical care units [J]. Critical Care, 11 (Suppl 2):
- [7] Audit of epilepsy services at a district general hospital as compared with the National Institute for Clinical Excellence guidelines [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2006, 48 : 36 - 36
- [10] Pharmacokinetics and clinical use of drotrecogin alfa (activated) in patients with severe sepsis [J]. PHARMACOTHERAPY, 2002, 22 (12): : 196S - 205S